P961: BORTEZOMIB, RITUXIMAB AND DEXAMETHASONE REGIMEN (BDR) IN WALDENSTRÖM MACROGLOBULINEMIA: A RETROSPECTIVE ANALYSIS

• Thomas Hueso,
• Ramy Rahme,
• Valerie Vidal,
• Sarah Ivanoff,
• Sabine Brechignac,
• Gregory Lazarian,
• David Ghez,
• Damien Roos-Weil,
• Fanny Baran-Marszak,
• Claude Gardin,
• Thorsten Braun

Affiliations

Thomas Hueso

1 Sorbonne Université Paris Nord

Ramy Rahme

2 Avicenne Hospital, Hematology, Bobigny, France

Valerie Vidal

2 Avicenne Hospital, Hematology, Bobigny, France

Sarah Ivanoff

2 Avicenne Hospital, Hematology, Bobigny, France

Sabine Brechignac

2 Avicenne Hospital, Hematology, Bobigny, France

Gregory Lazarian

2 Avicenne Hospital, Hematology, Bobigny, France

David Ghez

3 Gustave Roussy, Hematology, Villejuif, France

Damien Roos-Weil

4 Pitié Salpétrière Hospital, Hematology, France

Fanny Baran-Marszak

1 Sorbonne Université Paris Nord

Claude Gardin

1 Sorbonne Université Paris Nord

Thorsten Braun

1 Sorbonne Université Paris Nord